Compare Abbott India with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DISHMAN PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DISHMAN PHARMA ABBOTT INDIA/
DISHMAN PHARMA
 
P/E (TTM) x 44.7 25.1 178.2% View Chart
P/BV x 12.8 3.3 382.7% View Chart
Dividend Yield % 0.5 0.7 81.1%  

Financials

 ABBOTT INDIA   DISHMAN PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
DISHMAN PHARMA
Mar-16
ABBOTT INDIA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs6,110374 1,631.9%   
Low Rs3,996129 3,100.1%   
Sales per share (Unadj.) Rs1,552.2197.8 784.7%  
Earnings per share (Unadj.) Rs188.821.2 890.3%  
Cash flow per share (Unadj.) Rs196.434.7 565.7%  
Dividends per share (Unadj.) Rs55.002.00 2,750.0%  
Dividend yield (eoy) %1.10.8 137.0%  
Book value per share (Unadj.) Rs796.6179.9 442.8%  
Shares outstanding (eoy) m21.2580.69 26.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.3 255.9%   
Avg P/E ratio x26.811.9 225.5%  
P/CF ratio (eoy) x25.77.2 354.9%  
Price / Book Value ratio x6.31.4 453.4%  
Dividend payout %29.19.4 308.9%   
Avg Mkt Cap Rs m107,37620,306 528.8%   
No. of employees `0003.30.8 400.7%   
Total wages/salary Rs m3,9375,355 73.5%   
Avg. sales/employee Rs Th9,929.319,252.7 51.6%   
Avg. wages/employee Rs Th1,185.16,459.5 18.3%   
Avg. net profit/employee Rs Th1,207.72,064.1 58.5%   
INCOME DATA
Net Sales Rs m32,98515,961 206.7%  
Other income Rs m1,170265 440.8%   
Total revenues Rs m34,15516,226 210.5%   
Gross profit Rs m5,2454,103 127.8%  
Depreciation Rs m1621,091 14.8%   
Interest Rs m38944 4.0%   
Profit before tax Rs m6,2152,334 266.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,203624 353.2%   
Profit after tax Rs m4,0121,711 234.5%  
Gross profit margin %15.925.7 61.9%  
Effective tax rate %35.426.7 132.6%   
Net profit margin %12.210.7 113.5%  
BALANCE SHEET DATA
Current assets Rs m22,65511,018 205.6%   
Current liabilities Rs m6,6819,517 70.2%   
Net working cap to sales %48.49.4 515.0%  
Current ratio x3.41.2 292.9%  
Inventory Days Days65110 58.6%  
Debtors Days Days2935 83.7%  
Net fixed assets Rs m83516,304 5.1%   
Share capital Rs m213161 131.7%   
"Free" reserves Rs m16,71512,907 129.5%   
Net worth Rs m16,92814,516 116.6%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m24,16229,805 81.1%  
Interest coverage x163.73.5 4,716.0%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.40.5 254.9%   
Return on assets %16.88.9 188.1%  
Return on equity %23.711.8 201.1%  
Return on capital %36.917.5 210.7%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m3694,952 7.4%   
Fx outflow Rs m3,807697 546.3%   
Net fx Rs m-3,4384,255 -80.8%   
CASH FLOW
From Operations Rs m1,5272,786 54.8%  
From Investments Rs m-2,148-1,529 140.5%  
From Financial Activity Rs m-1,024-941 108.8%  
Net Cashflow Rs m-1,646316 -520.1%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 3.7 213.5%  
FIIs % 0.1 12.7 0.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 22.1 77.4%  
Shareholders   18,270 46,261 39.5%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   GLENMARK PHARMA  J.B.CHEMICALS  PROCTER & GAMBLE HEALTH  DIVIS LABORATORIES  FULFORD INDIA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Sep 20, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS